Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.14701/ahbps.2020.24.4.526 http://scihub22266oqcxt.onion/10.14701/ahbps.2020.24.4.526 33234758!7691211!33234758     free     free     free       Ann+Hepatobiliary+Pancreat+Surg 2020 ; 24 (4): 526-532 Nephropedia Template TP {{tp|p=33234758|t=2020. Convalescent plasma therapy and remdesivir duo successfully salvaged an early liver transplant recipient with severe COVID-19 pneumonia |pdf=|usr=}}{{33234758}} gab.com Text Convalescent plasma therapy and remdesivir duo successfully salvaged an early liver transplant recipient with severe COVID-19 pneumonia JO: Ann Hepatobiliary Pancreat Surg http://www.kidney.de/pget.php?&tw=1&pmid=33234758 #FOAvip The impact and clinical spectrum of COVID-19 infection in liver transplant recipients/solid organ transplants are being unveiled during this recent pandemic. The clinical experience of use of current antiviral drugs and immunomodulators are sparse in solid organ transplantation. We present the clinical course of a 49-year-old male recipient who underwent living donor liver transplant for recurrent gastrointestinal bleed and contracted severe COVID-19 pneumonia during the third postoperative week. Herein we report the successful management of severe COVID-19 pneumonia using convalescent plasma therapy and remdesivir. Recipient's clinical deterioration was halted after three consecutive convalescent plasma transfusions with improvement in hypoxia and inflammatory markers (interleukin-6 and C-reactive protein). The use of convalescent plasma therapy along with remdesivir may be an ideal combination in the management of severe COVID-19 pneumonia in solid organ transplant recipients. Twit Text FOAVip Convalescent plasma therapy and remdesivir duo successfully salvaged an early liver transplant recipient with severe COVID-19 pneumonia ????Ann Hepatobiliary Pancreat Surg http://www.kidney.de/pget.php?&tw=1&pmid=33234758 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33234758 #FOAvip English Wikipedia <ref>{{Cite pmid|33234758}}</ref> Convalescent plasma therapy and remdesivir duo successfully salvaged an early liver transplant recipient with severe COVID-19 pneumonia #MMPMID33234758 Jamir I; Lohia P; Pande RK; Setia R; Singhal AK; Chaudhary A Ann Hepatobiliary Pancreat Surg 2020[Nov]; 24 (4): 526-532 PMID33234758show ga The impact and clinical spectrum of COVID-19 infection in liver transplant recipients/solid organ transplants are being unveiled during this recent pandemic. The clinical experience of use of current antiviral drugs and immunomodulators are sparse in solid organ transplantation. We present the clinical course of a 49-year-old male recipient who underwent living donor liver transplant for recurrent gastrointestinal bleed and contracted severe COVID-19 pneumonia during the third postoperative week. Herein we report the successful management of severe COVID-19 pneumonia using convalescent plasma therapy and remdesivir. Recipient's clinical deterioration was halted after three consecutive convalescent plasma transfusions with improvement in hypoxia and inflammatory markers (interleukin-6 and C-reactive protein). The use of convalescent plasma therapy along with remdesivir may be an ideal combination in the management of severe COVID-19 pneumonia in solid organ transplant recipients. ?Convalescent plasma therapy and remdesivir duo successfully salvaged a(epmc).pdf DeepDyve Pubget Overpricing